✦ LIBER ✦

Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience

✍ Scribed by Daisuke Tanioka; Yoshiaki Iwasaki; Yasuyuki Araki; Toshiya Osawa; Hiroshi Ikeda; Masaharu Ando; Haruhiko Kobashi; Kohsaku Sakaguchi; Yasushi Shiratori; Kazuhide Yamamoto

Book ID: 111239039
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 200 KB
Volume: 29
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2008.01964.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Factors associated with hemolytic anemia

Factors associated with hemolytic anemia in patients with chronic hepatitis C treated with combination of interferon and ribavirin

✍ Cheng Hou; M.L. Yu; C.Y. Dai; W.L. Chuang; S.C. Chen; Z.Y. Lin; L.Y. Wang; W.Y. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Treatment of chronic hepatitis C patient

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?

✍ Wolfgang Vogel 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 440 KB

Thyroid dysfunction in patients with chr

Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis

✍ Kwong-Ming Kee; Chuan-Mo Lee; Jing-Houng Wang; Hung-Da Tung; Chi-Sin Changchien; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Efficacy of rebetron (interferon and rib

Efficacy of rebetron (interferon and ribavirin) combination therapy in the treatment of patients with chronic hepatitis C not previously treated with interferon

✍ Joseph Geenen E; Daniel Geenen J; Marc Catalano F; Michael Schmalz J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB